A detailed history of Cibc World Markets Corp transactions in Illumina, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 20,089 shares of ILMN stock, worth $2.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,089
Previous 26,369 23.82%
Holding current value
$2.89 Million
Previous $3.62 Million 42.1%
% of portfolio
0.01%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$101.05 - $133.57 $634,594 - $838,819
-6,280 Reduced 23.82%
20,089 $2.1 Million
Q1 2024

May 13, 2024

SELL
$127.73 - $147.2 $4.07 Million - $4.69 Million
-31,857 Reduced 54.71%
26,369 $3.62 Million
Q4 2023

Feb 13, 2024

BUY
$92.79 - $142.53 $2.9 Million - $4.46 Million
31,278 Added 116.07%
58,226 $8.11 Million
Q3 2023

Nov 13, 2023

SELL
$128.91 - $192.44 $620,314 - $926,021
-4,812 Reduced 15.15%
26,948 $3.7 Million
Q2 2023

Aug 04, 2023

BUY
$183.43 - $232.67 $4.02 Million - $5.1 Million
21,910 Added 222.44%
31,760 $5.95 Million
Q1 2023

May 11, 2023

SELL
$193.75 - $232.55 $4.36 Million - $5.24 Million
-22,513 Reduced 69.56%
9,850 $2.29 Million
Q4 2022

Feb 09, 2023

BUY
$187.24 - $242.74 $5.61 Million - $7.28 Million
29,979 Added 1257.51%
32,363 $6.54 Million
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $3.07 Million - $3.95 Million
-17,347 Reduced 87.92%
2,384 $455,000
Q2 2022

Aug 12, 2022

SELL
$181.58 - $368.0 $3.08 Million - $6.24 Million
-16,967 Reduced 46.23%
19,731 $3.64 Million
Q1 2022

May 13, 2022

BUY
$303.87 - $423.8 $1.16 Million - $1.61 Million
3,801 Added 11.55%
36,698 $12.8 Million
Q4 2021

Feb 11, 2022

SELL
$347.28 - $421.83 $2.21 Million - $2.69 Million
-6,374 Reduced 16.23%
32,897 $12.5 Million
Q3 2021

Nov 12, 2021

BUY
$405.61 - $524.84 $11.2 Million - $14.5 Million
27,552 Added 235.11%
39,271 $15.9 Million
Q2 2021

Aug 10, 2021

SELL
$372.84 - $481.5 $2.9 Million - $3.74 Million
-7,774 Reduced 39.88%
11,719 $5.55 Million
Q1 2021

May 07, 2021

SELL
$361.28 - $504.76 $7.39 Million - $10.3 Million
-20,461 Reduced 51.21%
19,493 $7.49 Million
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $694,577 - $880,288
2,373 Added 6.31%
39,954 $14.8 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $3.66 Million - $5.46 Million
13,619 Added 56.84%
37,581 $11.6 Million
Q2 2020

Aug 12, 2020

BUY
$256.46 - $373.01 $270,052 - $392,779
1,053 Added 4.6%
23,962 $8.87 Million
Q1 2020

May 12, 2020

SELL
$209.2 - $335.53 $1.35 Million - $2.17 Million
-6,465 Reduced 22.01%
22,909 $6.26 Million
Q4 2019

Feb 13, 2020

SELL
$288.29 - $335.49 $8.28 Million - $9.64 Million
-28,731 Reduced 49.45%
29,374 $9.75 Million
Q3 2019

Nov 12, 2019

BUY
$266.84 - $378.23 $6.54 Million - $9.27 Million
24,515 Added 72.98%
58,105 $17.7 Million
Q2 2019

Aug 13, 2019

SELL
$300.59 - $368.15 $480,342 - $588,303
-1,598 Reduced 4.54%
33,590 $12.4 Million
Q1 2019

May 14, 2019

SELL
$272.57 - $321.18 $3.69 Million - $4.35 Million
-13,553 Reduced 27.81%
35,188 $10.9 Million
Q4 2018

Feb 13, 2019

BUY
$272.46 - $366.54 $1.24 Million - $1.67 Million
4,545 Added 10.28%
48,741 $14.6 Million
Q3 2018

Nov 13, 2018

SELL
$279.04 - $367.06 $5.99 Million - $7.88 Million
-21,474 Reduced 32.7%
44,196 $16.2 Million
Q2 2018

Aug 13, 2018

BUY
$228.17 - $292.07 $8.77 Million - $11.2 Million
38,418 Added 140.97%
65,670 $18.3 Million
Q1 2018

May 11, 2018

SELL
$209.54 - $253.91 $3.37 Million - $4.08 Million
-16,064 Reduced 37.09%
27,252 $6.44 Million
Q4 2017

Feb 13, 2018

SELL
$202.23 - $230.03 $5.72 Million - $6.51 Million
-28,298 Reduced 39.51%
43,316 $9.46 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $12.3 Million - $15.3 Million
71,614
71,614 $14.3 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Cibc World Markets Corp Portfolio

Follow Cibc World Markets Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Markets Corp, based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Markets Corp with notifications on news.